openPR Logo
Press release

Enteric Disease Testing Market Size (USD 5.3 Billion by 2032) Achieves Record-breaking Growth in Meeting Healthcare Requirements

08-18-2023 08:28 AM CET | Health & Medicine

Press release from: Allied Market Research (AMR)

Enteric Disease Testing Market

Enteric Disease Testing Market

Allied Market Research published a report, titled, "Enteric Disease Testing Market By Product Type (Reagents and Consumables, Equipment), By Technique (Molecular Diagnostics, Immunodiagnostics), By Disease Type (Bacterial Enteric Disease, Viral Enteric Disease, Parasitic Enteric Disease), By End User (Hospital Laboratories, Pharmaceutical, and Biotechnology Companies, Academic and Research Institutes): Global Opportunity Analysis And Industry Forecast, 2022-2032โ€ณ. According to the report, the global Enteric Disease Testing Market Size was Valued at USD 3.8 Billion in 2022 and is Projected to Garner USD 5.3 billion by 2032, registering a CAGR of 3.3% from 2023 to 2032.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ ๐จ๐Ÿ ๐‚๐จ๐ฏ๐ข๐-๐Ÿ๐Ÿ— ๐จ๐ง ๐„๐ง๐ญ๐ž๐ซ๐ข๐œ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ

โ€ข Due to the COVID-19 pandemic and the subsequent global lockdowns, the enteric disease testing market faced a downturn.
โ€ข However, as the global situation started ameliorating, the demand for enteric disease testing product was restored back. This, in turn, presented various growth opportunities for companies operating in the enteric disease testing market.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐‡๐ž๐ซ๐ž:
https://www.alliedmarketresearch.com/request-sample/295

๐–๐ก๐š๐ญ ๐€๐ซ๐ž ๐ญ๐ก๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐Ÿ๐จ๐ซ ๐„๐ง๐ญ๐ž๐ซ๐ข๐œ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ž๐ฌ๐ญ๐ข๐ง๐ ?

Increase in awareness in developing countries regarding diagnosis of infectious enteric diseases, easy availability of testing reagents of enteric disease, and technological advancement in testing equipment of enteric diseases drive the growth of the global enteric disease testing market. However, the high cost associated with molecular diagnostic assay is hampering the enteric disease testing market growth. On the contrary, the increase in adoption of key strategies by key players is expected to offer remunerative opportunities for expansion of the enteric disease testing market during the forecast period.

๐“๐จ๐ฉ ๐„๐ง๐ญ๐ž๐ซ๐ข๐œ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ

โ€ข Abbott Laboratories
โ€ข Becton Dickinson & Company
โ€ข Biomerica Inc.
โ€ข Biomerieux SA
โ€ข Bio-Rad Laboratories Inc.
โ€ข Coris Bioconcept
โ€ข Diasorin S.p.A.
โ€ข Meridian Bioscience Inc
โ€ข Quest Diagnostics
โ€ข Trinity

๐„๐ง๐ญ๐ž๐ซ๐ข๐œ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: -

Based on product type, the reagents and
consumables segment held the highest market share in 2022, accounting for more than two-thirds of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to rise in number of market players who manufactures reagents and consumables and increase in awareness among people regarding use of kits for diagnosis of enteric disease.

Based on technique, the immunodiagnostics segment held the highest market share in 2022, accounting for more than three-fifths of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to high adoption of immunodiagnostics technique and increase in technological advancement in immunodiagnostic technique.

Based on end user, the hospital laboratories segment held the highest market share in terms of revenue in 2022, accounting for around four-fifths of the global enteric disease testing market revenue, and is estimated to maintain its leadership status throughout the forecast period.

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to robust healthcare infrastructure, presence of key players, and rise in healthcare expenditure. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.2% from 2023 to 2032, owing to an increase in awareness related to use of enteric disease testing products, unmet medical demands, and high population base.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/295

Our Market Research Solution Provides You Answer to Below Mentioned Question:

โ€ข Which are the driving factors responsible for the growth of market?
โ€ข Which are the roadblock factors of this market?
โ€ข What are the new opportunities, by which market will grow in coming years?
โ€ข What are the trends of this market?
โ€ข Which are main factors responsible for new product launch?
โ€ข How big is the global & regional market in terms of revenue, sales and production?
โ€ข How far will the market grow in forecast period in terms of revenue, sales and production?
โ€ข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โ€ข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โ€ข Which region has more opportunities?

By Region Outlook

โ€ข North America
(U.S., Canada, Mexico)
โ€ข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โ€ข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โ€ข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Enteric Disease Testing Market Size (USD 5.3 Billion by 2032) Achieves Record-breaking Growth in Meeting Healthcare Requirements here

News-ID: 3170142 • Views: โ€ฆ

More Releases from Allied Market Research (AMR)

Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million by 2027 at a CAGR of 12.34%
Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million โ€ฆ
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521 Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in realโ€ฆ
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Business Development Forecast to 2032
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines โ€ฆ
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849 Market Drivers and Challenges: - The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,โ€ฆ
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key Manufacturers Analysis to 2032
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key โ€ฆ
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654 What is Sunflower Lecithin? Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarilyโ€ฆ
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156 Market Drivers, Restraints, and Opportunities Drivers: - Technological advancements and innovations inโ€ฆ

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease โ€ฆ
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.โ€ฆ
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas โ€ฆ
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by theโ€ฆ
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind โ€ฆ
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohnโ€™s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcoholโ€ฆ
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, andโ€ฆ
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing geneโ€ฆ
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news andโ€ฆ